Corporate DealsLicense Agreement SignedOct 5, 2026 · 7:00am ET
ALECAlector, Inc.
Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy
Agreement focuses on treatment for Parkinson’s Disease and other neurodegenerative diseases.